Lipella Pharmaceuticals Inc. (LIPO)
NASDAQ: LIPO · Real-Time Price · USD
2.410
-0.080 (-3.21%)
At close: Nov 20, 2024, 4:00 PM
2.370
-0.040 (-1.66%)
After-hours: Nov 20, 2024, 5:33 PM EST
Lipella Pharmaceuticals Market Cap
Lipella Pharmaceuticals has a market cap or net worth of $2.91 million as of November 21, 2024. Its market cap has decreased by -53.94% in one year.
Market Cap
2.91M
Enterprise Value
1.63M
1-Year Change
-53.94%
Ranking
Category
Stock Price
$2.41
Market Cap Chart
Since the IPO on December 20, 2022, Lipella Pharmaceuticals's market cap has decreased from $32.74M to $2.91M, a decrease of -91.10%. That is a compound annual growth rate of -71.67%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 19, 2024 | 3.01M | -49.15% |
| Dec 29, 2023 | 5.92M | -67.07% |
| Dec 30, 2022 | 17.98M | -45.08% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Palisade Bio | 3.15M |
| NuCana | 3.12M |
| Enveric Biosciences | 3.12M |
| Oncternal Therapeutics | 3.09M |
| iSpecimen | 3.07M |
| Aditxt | 2.97M |
| Matinas BioPharma Holdings | 2.95M |
| Theriva Biologics | 2.93M |